{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T20:50:44Z","timestamp":1783716644367,"version":"3.55.0"},"reference-count":130,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,7]],"date-time":"2022-04-07T00:00:00Z","timestamp":1649289600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biophysical Chemistry"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.bpc.2022.106805","type":"journal-article","created":{"date-parts":[[2022,3,26]],"date-time":"2022-03-26T17:35:43Z","timestamp":1648316143000},"page":"106805","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Computational design of a \u03b2-wrapin's N-terminal domain with canonical and non-canonical amino acid modifications mimicking curcumin's proposed inhibitory function"],"prefix":"10.1016","volume":"286","author":[{"given":"Asuka A.","family":"Orr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah K.","family":"Kuhlmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phanourios","family":"Tamamis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bpc.2022.106805_bb0005","series-title":"Molecular Biology of the Cell","article-title":"The shape and structure of proteins","author":"Alberts","year":"2002"},{"key":"10.1016\/j.bpc.2022.106805_bb0010","doi-asserted-by":"crossref","first-page":"D327","DOI":"10.1093\/nar\/gks991","article-title":"SwissSidechain: a molecular and structural database of non-natural sidechains","volume":"41","author":"Gfeller","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bpc.2022.106805_bb0015","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1021\/acschembio.7b00974","article-title":"Playing with the molecules of Life","volume":"13","author":"Young","year":"2018","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.bpc.2022.106805_bb0020","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1007\/s00253-019-09690-6","article-title":"Incorporation of non-standard amino acids into proteins: challenges, recent achievements, and emerging applications","volume":"103","author":"Jin","year":"2019","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.bpc.2022.106805_bb0025","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.drudis.2016.11.003","article-title":"Peptidomimetic therapeutics: scientific approaches and opportunities","volume":"22","author":"Qvit","year":"2017","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.bpc.2022.106805_bb0030","doi-asserted-by":"crossref","first-page":"8411","DOI":"10.1021\/ja502851h","article-title":"A genetically encoded aza-Michael acceptor for covalent cross-linking of protein-receptor complexes","volume":"136","author":"Furman","year":"2014","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bpc.2022.106805_bb0035","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1021\/acs.molpharmaceut.5b00082","article-title":"Antibody conjugates with unnatural amino acids","volume":"12","author":"Hallam","year":"2015","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.bpc.2022.106805_bb0040","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.cbpa.2018.07.018","article-title":"Harnessing the power of an expanded genetic code toward next-generation biopharmaceuticals","volume":"46","author":"Kang","year":"2018","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.bpc.2022.106805_bb0045","doi-asserted-by":"crossref","first-page":"3185","DOI":"10.2174\/138161210793292555","article-title":"Chemical modifications designed to improve peptide stability: incorporation of non-natural amino acids, pseudo-peptide bonds, and cyclization","volume":"16","author":"Gentilucci","year":"2010","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.bpc.2022.106805_bb0050","doi-asserted-by":"crossref","first-page":"11052","DOI":"10.1073\/pnas.1108045108","article-title":"Evolution of cyclic peptide protease inhibitors","volume":"108","author":"Young","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bpc.2022.106805_bb0055","doi-asserted-by":"crossref","first-page":"753","DOI":"10.2174\/187152010794728639","article-title":"Cilengitide: the first anti-angiogenic small molecule drug candidate design, synthesis and clinical evaluation","volume":"10","author":"Mas-Moruno","year":"2010","journal-title":"Anti Cancer Agents Med. Chem."},{"key":"10.1016\/j.bpc.2022.106805_bb0060","doi-asserted-by":"crossref","first-page":"6961","DOI":"10.1073\/pnas.1507741112","article-title":"Exploring the potential impact of an expanded genetic code on protein function","volume":"112","author":"Xiao","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bpc.2022.106805_bb0065","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/nchembio.2002","article-title":"Addicting diverse bacteria to a noncanonical amino acid","volume":"12","author":"Tack","year":"2016","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.bpc.2022.106805_bb0070","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1021\/ja00897a025","article-title":"Solid phase peptide synthesis. I. the synthesis of a tetrapeptide","volume":"85","author":"Merrifield","year":"1963","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bpc.2022.106805_bb0075","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1021\/ar200056q","article-title":"A \u201ctag-and-modify\u201d approach to site-selective protein modification","volume":"44","author":"Chalker","year":"2011","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.bpc.2022.106805_bb0080","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.cbpa.2010.10.007","article-title":"Chemical mutagenesis: selective post-expression interconversion of protein amino acid residues","volume":"14","author":"Chalker","year":"2010","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.bpc.2022.106805_bb0085","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.cbpa.2010.09.013","article-title":"Residue-specific incorporation of non-canonical amino acids into proteins: recent developments and applications","volume":"14","author":"Johnson","year":"2010","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.bpc.2022.106805_bb0090","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/nature08817","article-title":"Encoding multiple unnatural amino acids via evolution of a quadruplet-decoding ribosome","volume":"464","author":"Neumann","year":"2010","journal-title":"Nature."},{"key":"10.1016\/j.bpc.2022.106805_bb0095","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1146\/annurev.biophys.35.101105.121507","article-title":"Expanding the genetic code","volume":"35","author":"Wang","year":"2006","journal-title":"Annu. Rev. Biophys. Biomol. Struct."},{"key":"10.1016\/j.bpc.2022.106805_bb0100","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1021\/sb400168u","article-title":"Forcefield_NCAA: ab initio charge parameters to aid in the discovery and design of therapeutic proteins and peptides with unnatural amino acids and their application to complement inhibitors of the compstatin family","volume":"3","author":"Khoury","year":"2014","journal-title":"ACS Synth. Biol."},{"key":"10.1016\/j.bpc.2022.106805_bb0105","doi-asserted-by":"crossref","first-page":"W235","DOI":"10.1093\/nar\/gkl163","article-title":"RosettaDesign server for protein design","volume":"34","author":"Liu","year":"2006","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bpc.2022.106805_bb0110","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/nature10154","article-title":"Structure-based design of non-natural amino-acid inhibitors of amyloid fibril formation","volume":"475","author":"Sievers","year":"2011","journal-title":"Nature."},{"key":"10.1016\/j.bpc.2022.106805_bb0115","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1021\/jm501345y","article-title":"New compstatin peptides containing N-terminal extensions and non-natural amino acids exhibit potent complement inhibition and improved solubility characteristics","volume":"58","author":"Gorham","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bpc.2022.106805_bb0120","doi-asserted-by":"crossref","first-page":"W409","DOI":"10.1093\/nar\/gks378","article-title":"ZINCPharmer: pharmacophore search of the ZINC database","volume":"40","author":"Koes","year":"2012","journal-title":"Nucleic Acids Res."},{"issue":"13","key":"10.1016\/j.bpc.2022.106805_bb0125","doi-asserted-by":"crossref","first-page":"6084","DOI":"10.1016\/S0021-9258(17)38495-8","article-title":"Microtubule-associated protein tau. A component of Alzheimer paired helical filaments","volume":"261","author":"Grundke-Iqbal","year":"1986","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.bpc.2022.106805_bb0130","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S0006-291X(84)80190-4","article-title":"Alzheimer\u2019s disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein","volume":"120","author":"Glenner","year":"1984","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"6645","key":"10.1016\/j.bpc.2022.106805_bb0135","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","article-title":"Alpha-synuclein in Lewy bodies","volume":"388","author":"Spillantini","year":"1997","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.bpc.2022.106805_bb0140","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1212\/01.WNL.0000165987.89198.65","article-title":"Cognitive differences in dementia patients with autopsy-verified AD, Lewy body pathology, or both","volume":"64","author":"Kraybill","year":"2005","journal-title":"Neurology"},{"issue":"5321","key":"10.1016\/j.bpc.2022.106805_bb0145","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","article-title":"Mutation in the alpha-synuclein gene identified in families with Parkinson\u2019s disease","volume":"276","author":"Polymeropoulos","year":"1997","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.bpc.2022.106805_bb0150","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/jnen\/61.5.413","article-title":"Where does parkinson disease pathology begin in the brain?","volume":"61","author":"Del Tredici","year":"2002","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"2","key":"10.1016\/j.bpc.2022.106805_bb0155","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson\u2019s disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bpc.2022.106805_bb0160","first-page":"49","article-title":"Amyloidosis of the islets of Langerhans. A restudy of islet hyalin in diabetic and non-diabetic individuals","volume":"38","author":"Ehrlich","year":"1961","journal-title":"Am. J. Pathol."},{"issue":"7","key":"10.1016\/j.bpc.2022.106805_bb0165","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/s41594-020-0442-4","article-title":"Cryo-EM structure of islet amyloid polypeptide fibrils reveals similarities with amyloid-\u03b2 fibrils","volume":"27","author":"R\u00f6der","year":"2020","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"19","key":"10.1016\/j.bpc.2022.106805_bb0170","doi-asserted-by":"crossref","first-page":"3913","DOI":"10.1016\/j.jmb.2019.07.001","article-title":"Structural insights into \u03b1-synuclein fibril polymorphism: effects of Parkinson\u2019s disease-related C-terminal truncations","volume":"431","author":"Ni","year":"2019","journal-title":"J. Mol. Biol."},{"issue":"7752","key":"10.1016\/j.bpc.2022.106805_bb0175","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/s41586-019-1026-5","article-title":"Novel tau filament fold in chronic traumatic encephalopathy encloses hydrophobic molecules","volume":"568","author":"Falcon","year":"2019","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.bpc.2022.106805_bb0180","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s00401-018-1914-z","article-title":"Tau filaments from multiple cases of sporadic and inherited Alzheimer\u2019s disease adopt a common fold","volume":"136","author":"Falcon","year":"2018","journal-title":"Acta Neuropathol."},{"issue":"1","key":"10.1016\/j.bpc.2022.106805_bb0185","doi-asserted-by":"crossref","first-page":"3609","DOI":"10.1038\/s41467-018-05971-2","article-title":"Cryo-EM of full-length \u03b1-synuclein reveals fibril polymorphs with a common structural kernel","volume":"9","author":"Li","year":"2018","journal-title":"Nat. Commun."},{"issue":"7721","key":"10.1016\/j.bpc.2022.106805_bb0190","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/s41586-018-0454-y","article-title":"Structures of filaments from Pick\u2019s disease reveal a novel tau protein fold","volume":"561","author":"Falcon","year":"2018","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.bpc.2022.106805_bb0195","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/s41422-018-0075-x","article-title":"Amyloid fibril structure of \u03b1-synuclein determined by cryo-electron microscopy","volume":"28","author":"Li","year":"2018","journal-title":"Cell Res."},{"key":"10.1016\/j.bpc.2022.106805_bb0200","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.36402","article-title":"Cryo-EM structure of alpha-synuclein fibrils","volume":"7","author":"Guerrero-Ferreira","year":"2018","journal-title":"Elife"},{"issue":"6359","key":"10.1016\/j.bpc.2022.106805_bb0205","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1126\/science.aao2825","article-title":"Fibril structure of amyloid-\u03b2(1\u201342) by cryo-electron microscopy","volume":"358","author":"Gremer","year":"2017","journal-title":"Science"},{"issue":"7662","key":"10.1016\/j.bpc.2022.106805_bb0210","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/nature23002","article-title":"Cryo-EM structures of tau filaments from Alzheimer\u2019s disease","volume":"547","author":"Fitzpatrick","year":"2017","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.bpc.2022.106805_bb0215","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1021\/acs.chemrev.0c01122","article-title":"Amyloid oligomers: a joint experimental\/computational perspective on Alzheimer\u2019s disease, Parkinson\u2019s Disease, type II diabetes, and amyotrophic lateral sclerosis","volume":"121","author":"Nguyen","year":"2021","journal-title":"Chem. Rev."},{"issue":"40","key":"10.1016\/j.bpc.2022.106805_bb0220","doi-asserted-by":"crossref","first-page":"8772","DOI":"10.1021\/acs.jpcb.0c05768","article-title":"Terminal capping of an amyloidogenic tau fragment modulates its fibrillation propensity","volume":"124","author":"Arya","year":"2020","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.bpc.2022.106805_bb0225","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/978-1-4939-7811-3_27","article-title":"Experimental and computational protocols for studies of cross-seeding amyloid assemblies","volume":"1777","author":"Ren","year":"2018","journal-title":"Methods Mol. Biol."},{"issue":"2\u20133","key":"10.1016\/j.bpc.2022.106805_bb0230","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jmb.2011.11.023","article-title":"Selective molecular recognition in amyloid growth and transmission and cross-species barriers","volume":"421","author":"Ma","year":"2012","journal-title":"J. Mol. Biol."},{"issue":"6","key":"10.1016\/j.bpc.2022.106805_bb0235","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1073\/pnas.1819592116","article-title":"Thermodynamic phase diagram of amyloid-\u03b2 (16\u201322) peptide","volume":"116","author":"Wang","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6","key":"10.1016\/j.bpc.2022.106805_bb0240","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aav8216","article-title":"Molecular insights into the surface-catalyzed secondary nucleation of amyloid-\u03b240 (A\u03b240) by the peptide fragment A\u03b216\u201322","volume":"5","author":"Bunce","year":"2019","journal-title":"Sci. Adv."},{"issue":"7","key":"10.1016\/j.bpc.2022.106805_bb0245","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1002\/pro.3421","article-title":"Seeding and cross-seeding fibrillation of N-terminal prion protein peptides PrP(120\u2013144)","volume":"27","author":"Wang","year":"2018","journal-title":"Protein Sci."},{"issue":"4","key":"10.1016\/j.bpc.2022.106805_bb0250","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1039\/C5CP03338A","article-title":"Amylin-A\u03b2 oligomers at atomic resolution using molecular dynamics simulations: a link between Type 2 diabetes and Alzheimer\u2019s disease","volume":"18","author":"Baram","year":"2016","journal-title":"Phys. Chem. Chem. Phys."},{"issue":"1","key":"10.1016\/j.bpc.2022.106805_bb0255","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1021\/acschemneuro.5b00204","article-title":"Non-amyloid-\u03b2 component of human \u03b1-synuclein oligomers induces formation of new A\u03b2 oligomers: insight into the mechanisms that link Parkinson\u2019s and Alzheimer\u2019s diseases","volume":"7","author":"Atsmon-Raz","year":"2016","journal-title":"ACS Chem. Neurosci."},{"issue":"17","key":"10.1016\/j.bpc.2022.106805_bb0260","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1021\/acschemneuro.1c00445","article-title":"Insights into the mechanistic perspective effect of insulin on the nonamyloidogenic component (NAC) and \u03b1-synuclein aggregation","volume":"12","author":"Abramov-Harpaz","year":"2021","journal-title":"ACS Chem. Neurosci."},{"issue":"31","key":"10.1016\/j.bpc.2022.106805_bb0265","doi-asserted-by":"crossref","first-page":"10005","DOI":"10.1021\/acs.jpcb.5b03760","article-title":"A proposed atomic structure of the self-assembly of the non-amyloid-\u03b2 component of human \u03b1-synuclein as derived by computational tools","volume":"119","author":"Atsmon-Raz","year":"2015","journal-title":"J. Phys. Chem. B"},{"issue":"9","key":"10.1016\/j.bpc.2022.106805_bb0270","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1016\/j.bbamem.2018.03.014","article-title":"Molecular mechanisms of membrane-associated amyloid aggregation: Computational perspective and challenges","volume":"1860","author":"Press-Sandler","year":"2018","journal-title":"Biochim. Biophys. Acta Biomembr."},{"issue":"18","key":"10.1016\/j.bpc.2022.106805_bb0275","doi-asserted-by":"crossref","first-page":"4244","DOI":"10.1039\/C8SC00481A","article-title":"Mechanistic perspective and functional activity of insulin in amylin aggregation","volume":"9","author":"Baram","year":"2018","journal-title":"Chem. Sci."},{"issue":"4","key":"10.1016\/j.bpc.2022.106805_bb0280","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/j.bpj.2009.05.042","article-title":"Polymorphism of Alzheimer\u2019s Abeta17\u201342 (p3) oligomers: the importance of the turn location and its conformation","volume":"97","author":"Miller","year":"2009","journal-title":"Biophys. J."},{"issue":"8","key":"10.1016\/j.bpc.2022.106805_bb0285","doi-asserted-by":"crossref","first-page":"4820","DOI":"10.1021\/cr900377t","article-title":"Polymorphism in Alzheimer Abeta amyloid organization reflects conformational selection in a rugged energy landscape","volume":"110","author":"Miller","year":"2010","journal-title":"Chem. Rev."},{"issue":"7","key":"10.1016\/j.bpc.2022.106805_bb0290","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.str.2004.04.018","article-title":"Pathway complexity of Alzheimer\u2019s beta-amyloid Abeta16\u201322 peptide assembly","volume":"12","author":"Santini","year":"2004","journal-title":"Structure."},{"issue":"14","key":"10.1016\/j.bpc.2022.106805_bb0295","doi-asserted-by":"crossref","first-page":"4410","DOI":"10.1021\/jp710592v","article-title":"Self-assembly of the beta2-microglobulin NHVTLSQ peptide using a coarse-grained protein model reveals a beta-barrel species","volume":"112","author":"Song","year":"2008","journal-title":"J. Phys. Chem. B"},{"issue":"1","key":"10.1016\/j.bpc.2022.106805_bb0300","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.bpj.2009.10.003","article-title":"Atomic-scale simulations confirm that soluble beta-sheet-rich peptide self-assemblies provide amyloid mimics presenting similar conformational properties","volume":"98","author":"Yu","year":"2010","journal-title":"Biophys. J."},{"key":"10.1016\/j.bpc.2022.106805_bb0305","first-page":"3919","article-title":"Molecular dynamics simulations of Alzheimer Abeta40 elongation and lateral association","volume":"13","author":"Zheng","year":"2008","journal-title":"Front. Biosci."},{"issue":"10","key":"10.1016\/j.bpc.2022.106805_bb0310","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1021\/acschemneuro.5b00192","article-title":"Cross-seeding interaction between \u03b2-amyloid and human islet amyloid polypeptide","volume":"6","author":"Hu","year":"2015","journal-title":"ACS Chem. Neurosci."},{"issue":"12","key":"10.1016\/j.bpc.2022.106805_bb0315","doi-asserted-by":"crossref","first-page":"5020","DOI":"10.1016\/j.bpj.2009.03.026","article-title":"Self-assembly of phenylalanine oligopeptides: insights from experiments and simulations","volume":"96","author":"Tamamis","year":"2009","journal-title":"Biophys. J."},{"issue":"7","key":"10.1016\/j.bpc.2022.106805_bb0320","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1021\/jp409988n","article-title":"Self-assembly of an aspartate-rich sequence from the adenovirus fiber shaft: insights from molecular dynamics simulations and experiments","volume":"118","author":"Tamamis","year":"2014","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.bpc.2022.106805_bb0325","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/978-1-4939-1486-9_3","article-title":"Combination of theoretical and experimental approaches for the design and study of fibril-forming peptides","volume":"1216","author":"Tamamis","year":"2014","journal-title":"Methods Mol. Biol."},{"issue":"11","key":"10.1016\/j.bpc.2022.106805_bb0330","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1002\/1873-3468.13096","article-title":"A novel amyloid designable scaffold and potential inhibitor inspired by GAIIG of amyloid beta and the HIV-1 V3 loop","volume":"592","author":"Kokotidou","year":"2018","journal-title":"FEBS Lett."},{"issue":"1","key":"10.1016\/j.bpc.2022.106805_bb0335","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3390\/biom10010007","article-title":"Designer amyloid cell-penetrating peptides for potential use as gene transfer vehicles","volume":"10","author":"Kokotidou","year":"2019","journal-title":"Biomolecules"},{"issue":"47","key":"10.1016\/j.bpc.2022.106805_bb0340","doi-asserted-by":"crossref","first-page":"15639","DOI":"10.1021\/jp9066718","article-title":"Amyloid-like self-assembly of peptide sequences from the adenovirus fiber shaft: insights from molecular dynamics simulations","volume":"113","author":"Tamamis","year":"2009","journal-title":"J. Phys. Chem. B"},{"issue":"56","key":"10.1016\/j.bpc.2022.106805_bb0345","doi-asserted-by":"crossref","first-page":"7766","DOI":"10.1039\/C8CC02263A","article-title":"A\u03b2 under stress: the effects of acidosis, Cu2+-binding, and oxidation on amyloid \u03b2-peptide dimers","volume":"54","author":"Liao","year":"2018","journal-title":"Chem. Commun. (Camb.)"},{"issue":"39","key":"10.1016\/j.bpc.2022.106805_bb0350","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2106210118","article-title":"Amyloid-\u03b2 peptide dimers undergo a random coil to \u03b2-sheet transition in the aqueous phase but not at the neuronal membrane","volume":"118","author":"Fatafta","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bpc.2022.106805_bb0355","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.sbi.2020.10.019","article-title":"Amyloid aggregation simulations: challenges, advances and perspectives","volume":"67","author":"Strodel","year":"2021","journal-title":"Curr. Opin. Struct. Biol."},{"issue":"2","key":"10.1016\/j.bpc.2022.106805_bb0360","doi-asserted-by":"crossref","first-page":"179","DOI":"10.2174\/156720508783954668","article-title":"A closer look at alpha-secretase","volume":"5","author":"Postina","year":"2008","journal-title":"Curr. Alzheimer Res."},{"issue":"3","key":"10.1016\/j.bpc.2022.106805_bb0365","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1750-3639.2000.tb00269.x","article-title":"Lewy bodies in Alzheimer\u2019s disease: a neuropathological review of 145 cases using \u03b1-synuclein immunohistochemistry","volume":"10","author":"Hamilton","year":"2006","journal-title":"Brain Pathol."},{"issue":"21","key":"10.1016\/j.bpc.2022.106805_bb0370","doi-asserted-by":"crossref","first-page":"7281","DOI":"10.1523\/JNEUROSCI.0490-10.2010","article-title":"Synergistic Interactions between Abeta, tau, and alpha-synuclein: acceleration of neuropathology and cognitive decline","volume":"30","author":"Clinton","year":"2010","journal-title":"J. Neurosci."},{"issue":"4","key":"10.1016\/j.bpc.2022.106805_bb0375","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/ana.23956","article-title":"Amylin deposition in the brain: a second amyloid in Alzheimer disease?","volume":"74","author":"Jackson","year":"2013","journal-title":"Ann. Neurol."},{"issue":"4","key":"10.1016\/j.bpc.2022.106805_bb0380","doi-asserted-by":"crossref","first-page":"842","DOI":"10.2337\/dc06-2011","article-title":"Type 2 diabetes and the risk of Parkinson\u2019s disease","volume":"30","author":"Hu","year":"2007","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.bpc.2022.106805_bb0385","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.2337\/dc10-1333","article-title":"Diabetes and the risk of developing Parkinson\u2019s disease in Denmark","volume":"34","author":"Schernhammer","year":"2011","journal-title":"Diabetes Care"},{"issue":"1\u20134","key":"10.1016\/j.bpc.2022.106805_bb0390","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3109\/00207459309003322","article-title":"The relationship between diabetes mellitus and Parkinson\u2019s disease","volume":"69","author":"Sandyk","year":"1993","journal-title":"Int. J. Neurosci."},{"key":"10.1016\/j.bpc.2022.106805_bb0395","article-title":"Analysis of the relationship between type II diabetes mellitus and Parkinson\u2019s disease: a systematic review","volume":"2019","author":"Camargo Maluf","year":"2019","journal-title":"Parkinsons Dis."},{"issue":"3","key":"10.1016\/j.bpc.2022.106805_bb0400","doi-asserted-by":"crossref","first-page":"580","DOI":"10.3390\/molecules25030580","article-title":"Amyloid-beta peptides trigger aggregation of alpha-synuclein in vitro","volume":"25","author":"K\u00f6ppen","year":"2020","journal-title":"Molecules."},{"issue":"2","key":"10.1016\/j.bpc.2022.106805_bb0405","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0171925","article-title":"\u03b1-Synuclein increases \u03b2-amyloid secretion by promoting \u03b2\u2212\/\u03b3-secretase processing of APP","volume":"12","author":"Roberts","year":"2017","journal-title":"PLoS One"},{"issue":"44","key":"10.1016\/j.bpc.2022.106805_bb0410","doi-asserted-by":"crossref","first-page":"12473","DOI":"10.1073\/pnas.1610371113","article-title":"Cross-talk between amyloidogenic proteins in type-2 diabetes and Parkinson\u2019s disease","volume":"113","author":"Horvath","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bpc.2022.106805_bb0415","doi-asserted-by":"crossref","first-page":"25589","DOI":"10.1038\/srep25589","article-title":"Type 3 diabetes: cross talk between differentially regulated proteins of type 2 diabetes mellitus and Alzheimer\u2019s disease","volume":"6","author":"Mittal","year":"2016","journal-title":"Sci. Rep."},{"issue":"25","key":"10.1016\/j.bpc.2022.106805_bb0420","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.1021\/acs.biochem.9b00215","article-title":"Tau Interacts with the C-terminal region of \u03b1-synuclein, promoting formation of toxic aggregates with distinct molecular conformations","volume":"58","author":"Dasari","year":"2019","journal-title":"Biochemistry"},{"issue":"11","key":"10.1016\/j.bpc.2022.106805_bb0425","doi-asserted-by":"crossref","first-page":"4757","DOI":"10.1021\/acschemneuro.9b00516","article-title":"Catalytic prion-like cross-talk between a key Alzheimer\u2019s disease Tau-fragment R3 and the type 2 diabetes peptide IAPP","volume":"10","author":"Arya","year":"2019","journal-title":"ACS Chem. Neurosci."},{"issue":"1","key":"10.1016\/j.bpc.2022.106805_bb0430","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.cell.2013.05.057","article-title":"Distinct \u03b1-synuclein strains differentially promote tau inclusions in neurons","volume":"154","author":"Guo","year":"2013","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.bpc.2022.106805_bb0435","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0003135","article-title":"Mechanisms of hybrid oligomer formation in the pathogenesis of combined Alzheimer\u2019s and Parkinson\u2019s diseases","volume":"3","author":"Tsigelny","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.bpc.2022.106805_bb0440","doi-asserted-by":"crossref","first-page":"5099","DOI":"10.1073\/pnas.0711731105","article-title":"Stabilization of a beta-hairpin in monomeric Alzheimer\u2019s amyloid-beta peptide inhibits amyloid formation","volume":"105","author":"Hoyer","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bpc.2022.106805_bb0445","doi-asserted-by":"crossref","first-page":"4227","DOI":"10.1002\/anie.201309001","article-title":"Sequestration of a \u03b2-hairpin for control of \u03b1-synuclein aggregation","volume":"53","author":"Mirecka","year":"2014","journal-title":"Angew. Chem. Int. Ed. Eng."},{"key":"10.1016\/j.bpc.2022.106805_bb0450","doi-asserted-by":"crossref","first-page":"33474","DOI":"10.1038\/srep33474","article-title":"\u03b2-Hairpin of islet amyloid polypeptide bound to an aggregation inhibitor","volume":"6","author":"Mirecka","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bpc.2022.106805_bb0455","doi-asserted-by":"crossref","first-page":"23209","DOI":"10.1074\/jbc.M114.560920","article-title":"Alternative conformations of the Tau repeat domain in complex with an engineered binding protein","volume":"289","author":"Gr\u00fcning","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bpc.2022.106805_bb0460","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/cbic.201402552","article-title":"A \u03b2-hairpin-binding protein for three different disease-related amyloidogenic proteins","volume":"16","author":"Shaykhalishahi","year":"2015","journal-title":"Chembiochem"},{"key":"10.1016\/j.bpc.2022.106805_bb0465","doi-asserted-by":"crossref","first-page":"12781","DOI":"10.1021\/acs.jpcb.6b08485","article-title":"Uncovering the binding and specificity of \u03b2-wrapins for amyloid-\u03b2 and \u03b1-synuclein","volume":"120","author":"Orr","year":"2016","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.bpc.2022.106805_bb0470","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.compchemeng.2018.02.013","article-title":"Elucidating the multi-targeted anti-amyloid activity and enhanced islet amyloid polypeptide binding of \u03b2-wrapins","volume":"116","author":"Orr","year":"2018","journal-title":"Comput. Chem. Eng."},{"issue":"10","key":"10.1016\/j.bpc.2022.106805_bb0475","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph15102093","article-title":"Curcumin, cardiometabolic health and dementia","volume":"15","author":"Kim","year":"2018","journal-title":"Int. J. Environ. Res. Public Health"},{"issue":"12","key":"10.1016\/j.bpc.2022.106805_bb0480","doi-asserted-by":"crossref","first-page":"8116","DOI":"10.4049\/jimmunol.174.12.8116","article-title":"Curcumin inhibits immunostimulatory function of dendritic cells: MAPKs and translocation of NF-kappa B as potential targets","volume":"174","author":"Kim","year":"2005","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.bpc.2022.106805_bb0485","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1208\/s12248-012-9444-4","article-title":"Highly stabilized curcumin nanoparticles tested in an in vitro blood-brain barrier model and in Alzheimer\u2019s disease Tg2576 mice","volume":"15","author":"Cheng","year":"2013","journal-title":"AAPS J."},{"issue":"7","key":"10.1016\/j.bpc.2022.106805_bb0490","doi-asserted-by":"crossref","first-page":"5892","DOI":"10.1074\/jbc.M404751200","article-title":"Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo","volume":"280","author":"Yang","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bpc.2022.106805_bb0495","doi-asserted-by":"crossref","first-page":"2038267","DOI":"10.1155\/2018\/2038267","article-title":"Curcumin effectively rescued Parkinson\u2019s disease-like phenotypes in a novel Drosophila melanogaster model with dUCH knockdown","volume":"2018","author":"Nguyen","year":"2018","journal-title":"Oxidative Med. Cell. Longev."},{"issue":"1","key":"10.1016\/j.bpc.2022.106805_bb0500","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2174\/138161212798918995","article-title":"Curcumin: a potential neuroprotective agent in Parkinson\u2019s disease","volume":"18","author":"Mythri","year":"2012","journal-title":"Curr. Pharm. Des."},{"issue":"2","key":"10.1016\/j.bpc.2022.106805_bb0505","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s10787-017-0402-8","article-title":"Curcumin affords neuroprotection and inhibits \u03b1-synuclein aggregation in lipopolysaccharide-induced Parkinson\u2019s disease model","volume":"26","author":"Sharma","year":"2018","journal-title":"Inflammopharmacology"},{"issue":"4","key":"10.1016\/j.bpc.2022.106805_bb0510","doi-asserted-by":"crossref","DOI":"10.3390\/nu12041032","article-title":"Dietary supplementation with curcumin reduce circulating levels of glycogen synthase kinase-3\u03b2 and islet amyloid polypeptide in adults with high risk of type 2 diabetes and Alzheimer\u2019s disease","volume":"12","author":"Thota","year":"2020","journal-title":"Nutrients"},{"issue":"8","key":"10.1016\/j.bpc.2022.106805_bb0515","doi-asserted-by":"crossref","DOI":"10.3390\/nu11081837","article-title":"Curcumin and type 2 diabetes mellitus: prevention and treatment","volume":"11","author":"Pivari","year":"2019","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.bpc.2022.106805_bb0520","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1186\/s13063-016-1702-9","article-title":"Curcumin and long-chain Omega-3 polyunsaturated fatty acids for Prevention of type 2 Diabetes (COP-D): study protocol for a randomised controlled trial","volume":"17","author":"Thota","year":"2016","journal-title":"Trials"},{"key":"10.1016\/j.bpc.2022.106805_bb0525","doi-asserted-by":"crossref","first-page":"5892","DOI":"10.1074\/jbc.M404751200","article-title":"Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo","volume":"280","author":"Yang","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bpc.2022.106805_bb0530","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1021\/acschemneuro.5b00214","article-title":"Curcumin attenuates amyloid-\u03b2 aggregate toxicity and modulates amyloid-\u03b2 aggregation pathway","volume":"7","author":"Thapa","year":"2016","journal-title":"ACS Chem. Neurosci."},{"issue":"3","key":"10.1016\/j.bpc.2022.106805_bb0535","doi-asserted-by":"crossref","first-page":"999","DOI":"10.3233\/JAD-170351","article-title":"Curcumin inhibits tau aggregation and disintegrates preformed Tau filaments in vitro","volume":"60","author":"Rane","year":"2017","journal-title":"J. Alzheimers Dis."},{"issue":"1","key":"10.1016\/j.bpc.2022.106805_bb0540","doi-asserted-by":"crossref","first-page":"19011","DOI":"10.1038\/s41598-019-55419-w","article-title":"Toxic tau oligomers modulated by novel curcumin derivatives","volume":"9","author":"Lo Cascio","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bpc.2022.106805_bb0545","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1021\/cn3001203","article-title":"Curcumin modulates \u03b1-synuclein aggregation and toxicity","volume":"4","author":"Singh","year":"2013","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.bpc.2022.106805_bb0555","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1021\/ml300147m","article-title":"Kinetic profile of amyloid formation in the presence of an aromatic inhibitor by nuclear magnetic resonance","volume":"3","author":"Liu","year":"2012","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.bpc.2022.106805_bb0560","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.bbrc.2012.05.013","article-title":"Curcumin modulates the self-assembly of the islet amyloid polypeptide by disassembling \u03b1-helix","volume":"422","author":"Sparks","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bpc.2022.106805_bb0565","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1021\/acs.jcim.9b00561","article-title":"Interactions between curcumin derivatives and amyloid-\u03b2 fibrils: insights from molecular dynamics simulations","volume":"60","author":"Jakubowski","year":"2020","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.bpc.2022.106805_bb0570","doi-asserted-by":"crossref","first-page":"5.6.1","DOI":"10.1002\/cpbi.3","article-title":"Comparative protein structure modeling using MODELLER","volume":"54","author":"Webb","year":"2016","journal-title":"Curr. Protoc. Bioinformatics"},{"key":"10.1016\/j.bpc.2022.106805_bb0575","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/nsmb.2991","article-title":"A\u03b2(1\u201342) fibril structure illuminates self-recognition and replication of amyloid in Alzheimer\u2019s disease","volume":"22","author":"Xiao","year":"2015","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.bpc.2022.106805_bb0580","doi-asserted-by":"crossref","first-page":"5967","DOI":"10.1016\/j.bmc.2011.08.052","article-title":"Solid-state NMR analysis of interaction sites of curcumin and 42-residue amyloid \u03b2-protein fibrils","volume":"19","author":"Masuda","year":"2011","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bpc.2022.106805_bb0585","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0024657","article-title":"Accelerating protein docking in ZDOCK using an advanced 3D convolution library","volume":"6","author":"Pierce","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.bpc.2022.106805_bb0590","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1002\/jcc.21287","article-title":"CHARMM: the biomolecular simulation program","volume":"30","author":"Brooks","year":"2009","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.bpc.2022.106805_bb0595","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1002\/jcc.23354","article-title":"CHARMM36 all-atom additive protein force field: validation based on comparison to NMR data","volume":"34","author":"Huang","year":"2013","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.bpc.2022.106805_bb0600","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.ejmech.2018.08.083","article-title":"Branched pentapeptides as potent inhibitors of the vascular endothelial growth factor 165 binding to Neuropilin-1: Design, synthesis and biological activity","volume":"158","author":"Tymecka","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bpc.2022.106805_bb0605","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22010072","article-title":"Urea-peptide hybrids as VEGF-A165\/NRP-1 complex inhibitors with improved receptor affinity and biological properties","volume":"22","author":"Puszko","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bpc.2022.106805_bb0610","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1002\/prot.340230412","article-title":"Knowledge-based protein secondary structure assignment","volume":"23","author":"Frishman","year":"1995","journal-title":"Proteins"},{"issue":"33\u20138","key":"10.1016\/j.bpc.2022.106805_bb0615","first-page":"27","article-title":"VMD: visual molecular dynamics","volume":"14","author":"Humphrey","year":"1996","journal-title":"J. Mol. Graph."},{"key":"10.1016\/j.bpc.2022.106805_bb0620","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1021\/ar000033j","article-title":"Calculating structures and free energies of complex molecules: combining molecular mechanics and continuum models","volume":"33","author":"Kollman","year":"2000","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.bpc.2022.106805_bb0625","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/jcc.10379","article-title":"Converging free energy estimates: MM-PB(GB)SA studies on the protein-protein complex Ras-Raf","volume":"25","author":"Gohlke","year":"2004","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.bpc.2022.106805_bb0630","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/prot.22890","article-title":"Kinetics, in silico docking, molecular dynamics, and MM-GBSA binding studies on prototype indirubins, KT5720, and staurosporine as phosphorylase kinase ATP-binding site inhibitors: the role of water molecules examined","volume":"79","author":"Hayes","year":"2011","journal-title":"Proteins"},{"key":"10.1016\/j.bpc.2022.106805_bb0635","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1001\/jamaneurol.2013.5847","article-title":"Amyloid-\u03b2 and tau: the trigger and bullet in Alzheimer disease pathogenesis","volume":"71","author":"Bloom","year":"2014","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.bpc.2022.106805_bb0640","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1038\/s41593-020-0687-6","article-title":"Synergy between amyloid-\u03b2 and tau in Alzheimer\u2019s disease","volume":"23","author":"Busche","year":"2020","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.bpc.2022.106805_bb0645","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/nm.4443","article-title":"Amyloid-\u03b2 plaques enhance Alzheimer\u2019s brain tau-seeded pathologies by facilitating neuritic plaque tau aggregation","volume":"24","author":"He","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.bpc.2022.106805_bb0650","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.ajpath.2014.11.016","article-title":"In vivo seeding and cross-seeding of localized amyloidosis: a molecular link between type 2 diabetes and Alzheimer disease","volume":"185","author":"Oskarsson","year":"2015","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bpc.2022.106805_bb0655","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.neuroscience.2013.07.009","article-title":"Molecular links between Alzheimer\u2019s disease and diabetes mellitus","volume":"250","author":"Yang","year":"2013","journal-title":"Neuroscience."}],"container-title":["Biophysical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301462222000473?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301462222000473?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T07:57:30Z","timestamp":1759564650000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301462222000473"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":130,"alternative-id":["S0301462222000473"],"URL":"https:\/\/doi.org\/10.1016\/j.bpc.2022.106805","relation":{},"ISSN":["0301-4622"],"issn-type":[{"value":"0301-4622","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Computational design of a \u03b2-wrapin's N-terminal domain with canonical and non-canonical amino acid modifications mimicking curcumin's proposed inhibitory function","name":"articletitle","label":"Article Title"},{"value":"Biophysical Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bpc.2022.106805","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106805"}}